Edwards Lifesciences Corp (EW)
Current ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 4,035,700 | 4,067,500 | 3,647,000 | 3,257,200 | 3,095,800 | 3,513,900 | 3,263,100 | 3,241,300 | 3,180,700 | 3,515,500 | 3,322,900 | 3,069,200 | 3,091,000 | 2,980,400 | 2,690,300 | 2,507,900 | 2,984,000 | 2,739,700 | 2,354,700 | 2,368,800 |
Total current liabilities | US$ in thousands | 1,195,400 | 1,238,900 | 1,157,200 | 1,082,000 | 1,022,400 | 917,900 | 969,100 | 949,900 | 1,032,300 | 966,500 | 886,200 | 799,000 | 893,900 | 846,300 | 873,200 | 746,900 | 902,400 | 775,800 | 697,000 | 646,500 |
Current ratio | 3.38 | 3.28 | 3.15 | 3.01 | 3.03 | 3.83 | 3.37 | 3.41 | 3.08 | 3.64 | 3.75 | 3.84 | 3.46 | 3.52 | 3.08 | 3.36 | 3.31 | 3.53 | 3.38 | 3.66 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $4,035,700K ÷ $1,195,400K
= 3.38
The current ratio of Edwards Lifesciences Corp has displayed some fluctuations over the past eight quarters. The current ratio measures the company's ability to meet its short-term financial obligations using its current assets, with higher ratios indicating stronger liquidity.
From the data provided, we observe that the current ratio has been above 3.0 in all quarters, indicating that the company has a healthy liquidity position. In the latest quarter (Q4 2023), the current ratio was at 3.38, showing a slight increase from the previous quarter's 3.28.
While a current ratio above 2.0 is generally considered acceptable, Edwards Lifesciences Corp has consistently maintained a current ratio well above this threshold, reflecting its strong ability to cover short-term obligations. However, it is important to monitor any downward trends in the current ratio over time, as sustained decreases may indicate potential liquidity challenges in the future.
Overall, based on the current ratio trend observed, Edwards Lifesciences Corp appears to have a solid liquidity position, which is essential for managing short-term financial obligations effectively.
Peer comparison
Dec 31, 2023